UTHR vs. IDCC

Last updated Jul 11, 2026

UTHR (United Therapeutics Corporation) and IDCC (InterDigital, Inc.) are both stocks. UTHR operates in Biotechnology (Healthcare), while IDCC operates in Telecom Services (Communication Services). Over the past 10 years, UTHR returned 17.09%/yr vs 18.69%/yr for IDCC. At a 0.25 correlation, their price movements are largely independent.

Performance

UTHR vs. IDCC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and InterDigital, Inc. (IDCC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, UTHR achieves a 12.28% return, which is significantly higher than IDCC's -16.22% return. Over the past 10 years, UTHR has underperformed IDCC with an annualized return of 17.09%, while IDCC has yielded a comparatively higher 18.69% annualized return.

UTHR

• 1D: -0.98%
• 1M: 0.30%
• 6M: 13.21%
• YTD: 12.28%
• 1Y: 85.12%
• 3Y*: 35.14%
• 5Y*: 23.86%
• 10Y*: 17.09%

IDCC

• 1D: -0.53%
• 1M: -4.01%
• 6M: -13.70%
• YTD: -16.22%
• 1Y: 18.65%
• 3Y*: 42.33%
• 5Y*: 32.45%
• 10Y*: 18.69%

*Multi-year figures are annualized to reflect compound growth (CAGR)

UTHR vs. IDCC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
UTHR United Therapeutics Corporation	12.28%	38.09%	60.46%	-20.93%	28.70%	42.35%	72.33%	-19.12%	-26.39%	3.15%
IDCC InterDigital, Inc.	-16.22%	66.05%	81.06%	123.67%	-29.25%	20.49%	14.28%	-16.11%	-11.23%	-15.34%

Correlation

The correlation between UTHR and IDCC is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.05
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (10Y) Calculated over the trailing 10-year period	0.22
Correlation (All Time) Calculated using the full available price history since Jun 17, 1999	0.25

The correlation between UTHR and IDCC shifts across timeframes, from 0.05 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap UTHR : $23.22B IDCC : $6.85B
EPS UTHR : $27.12 IDCC : $10.37
PE Ratio UTHR : 20.17 IDCC : 25.53
PEG Ratio UTHR : 0.66 IDCC : 0.32
PS Ratio UTHR : 8.19 IDCC : 11.29
PB Ratio UTHR : 4.38 IDCC : 8.46
Total Revenue (TTM) UTHR : $3.17B IDCC : $828.92M
Gross Profit (TTM) UTHR : $2.74B IDCC : $537.64M
EBITDA (TTM) UTHR : $1.75B IDCC : $508.15M

Return for Risk

UTHR vs. IDCC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTHR

UTHR Risk / Return Rank: 94
UTHR Sharpe Ratio Rank: 88
UTHR Sortino Ratio Rank: 96
UTHR Omega Ratio Rank: 94
UTHR Calmar Ratio Rank: 97
UTHR Martin Ratio Rank: 96

IDCC

IDCC Risk / Return Rank: 56
IDCC Sharpe Ratio Rank: 58
IDCC Sortino Ratio Rank: 55
IDCC Omega Ratio Rank: 55
IDCC Calmar Ratio Rank: 56
IDCC Martin Ratio Rank: 57

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UTHR vs. IDCC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and InterDigital, Inc. (IDCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	UTHR	IDCC	Difference
Sharpe ratio: Return per unit of total volatility	1.74	0.35	+1.39
Sortino ratio: Return per unit of downside risk	3.93	0.82	+3.10
Omega ratio: Gain probability vs. loss probability	1.45	1.11	+0.34
Calmar ratio: Return relative to maximum drawdown	7.77	0.46	+7.31
Martin ratio: Return relative to average drawdown	16.43	0.98	+15.46

UTHR vs. IDCC - Sharpe Ratio Comparison

The current UTHR Sharpe Ratio is 1.74, which is higher than the IDCC Sharpe Ratio of 0.35. The chart below compares the historical Sharpe Ratios of UTHR and IDCC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

UTHR vs. IDCC - Drawdown Comparison

The maximum UTHR drawdown since its inception was -93.18%, roughly equal to the maximum IDCC drawdown of -93.83%. Use the drawdown chart below to compare losses from any high point for UTHR and IDCC.

Drawdown Indicators

	UTHR	IDCC	Difference
Max Drawdown Largest peak-to-trough decline	-93.18%	-93.83%	+0.65%
Max Drawdown (1Y) Largest decline over 1 year	-10.64%	-36.48%	+25.84%
Max Drawdown (3Y) Largest decline over 3 years	-33.00%	-36.48%	+3.48%
Max Drawdown (5Y) Largest decline over 5 years	-33.00%	-44.99%	+11.99%
Max Drawdown (10Y) Largest decline over 10 years	-55.56%	-64.94%	+9.38%
Current Drawdown Current decline from peak	-8.33%	-32.73%	+24.40%
Average Drawdown Average peak-to-trough decline	-35.24%	-45.24%	+10.00%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.03%	17.00%	-11.97%

Volatility

UTHR vs. IDCC - Volatility Comparison

The current volatility for United Therapeutics Corporation (UTHR) is 5.97%, while InterDigital, Inc. (IDCC) has a volatility of 13.08%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than IDCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UTHR	IDCC	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.97%	13.08%	-7.11%
Volatility (6M) Calculated over the trailing 6-month period	25.88%	35.85%	-9.97%
Volatility (1Y) Calculated over the trailing 1-year period	47.51%	47.56%	-0.05%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.03%	35.90%	-0.87%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	34.96%	35.60%	-0.64%

Dividends

UTHR vs. IDCC - Dividend Comparison

UTHR has not paid dividends to shareholders, while IDCC's dividend yield for the trailing twelve months is around 1.06%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
IDCC InterDigital, Inc.	1.06%	0.74%	0.85%	1.34%	2.83%	1.95%	2.31%	2.57%	2.11%	1.64%	0.99%	1.63%
UTHR United Therapeutics Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

UTHR vs. IDCC - Profitability Comparison

The chart below illustrates the profitability comparison between United Therapeutics Corporation and InterDigital, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

UTHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.

IDCC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, InterDigital, Inc. reported a gross profit of 0.00 and revenue of 205.42M. Therefore, the gross margin over that period was 0.0%.

UTHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.

IDCC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, InterDigital, Inc. reported an operating income of 82.26M and revenue of 205.42M, resulting in an operating margin of 40.1%.

UTHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.

IDCC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, InterDigital, Inc. reported a net income of 75.33M and revenue of 205.42M, resulting in a net margin of 36.7%.

Frequently Asked Questions

Can I hold both UTHR and IDCC in my portfolio?

UTHR and IDCC have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, UTHR or IDCC?

IDCC has higher volatility (13.08%) compared to UTHR (5.97%). In terms of maximum drawdown, UTHR dropped -93.18% vs IDCC's -93.83%.

Which has better risk-adjusted returns?

UTHR currently has the higher Sharpe Ratio (1.74 vs 0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.